Cancer subtypes | Podium presentations published within 3 years | P value | ||
2017 | 2018 | 2017–2018 | ||
Ovarian | 13 (46.4%) | 17 (54.8%) | 30 (52.6%) | p=0.23 |
Endometrial | 11 (84.6%) | 9 (56.3%) | 20 (69.0%) | p=0.15 |
Cervical | 8 (57.1%) | 6 (46.2%) | 14 (51.9%) | p=0.56 |
Vulvar | 0 (0%) | 0 (0%) | 0 (0%) | p=0.25 |
Misc | 11 (57.9%) | 15 (65.2%) | 26 (61.9%) | p=0.45 |
Total | 43 (57.3%) | 47 (56.6%) | 90 (57.0.%) |
Podium presentations are subdivided by cancer subtype for the SGO 2017 and 2018 Annual Meetings. Noted above are the podium presentations that were published within 3 years grouped by cancer type. The p-values listed above compare the correlation between the combined cancer subtype and likelihood of publication within 3 years.
Misc, miscellaneous.